摘要
目的:探讨临床药师在个体化抗血小板治疗中的作用。方法:回顾临床药师参与1例经皮冠状动脉介入术后支架内血栓形成的抗血小板治疗的案例。结果:临床药师通过患者基因型、药物相互作用、疾病等因素分析支架内血栓形成的原因,并参与药物治疗和药学监护,为临床实施个体化抗血小板治疗提供用药参考。结论:临床药师通过基因检测为患者实施个体化抗血小板治疗,保障患者用药安全、有效。
OBJECTIVE To evaluate the role of clinical pharmacist in individualized antiplatelet therapy. METHODS To review the clinical pharmacist participating in individualized antiplatelet therapy in one patient with stent thrombosis after per- cutaneous coronary intervention （PCI）. RESULTS Clinical pharmacist analyzed the causes of stent thrombosis after PCI by genotype, drug interaction,disease,etc, and took part in the drug treatment and pharmaceutical care to provide the individualized antiplatelet therapy. CONCLUSION Clinical pharmacist implements individualized antiplatelet therapy by gene detection to en- sure the safety and effectiveness of drug use.
出处
《中国医院药学杂志》
CAS
CSCD
北大核心
2014年第10期852-855,共4页
Chinese Journal of Hospital Pharmacy
